The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Elymbus 0.1 mg/g eye gel in single-dose container



Laboratoires TheaPA1107/019/001

Main Information

Trade NameElymbus 0.1 mg/g eye gel in single-dose container
Active SubstancesBimatoprost
Dosage FormEye gel in single-dose container
Licence HolderLaboratoires Thea
Licence NumberPA1107/019/001

Group Information

ATC CodeS01EE03 bimatoprost

Status

License statusAuthorised
Licence Issued23/06/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back